<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/">

    <channel>
    
    <title>Signature Communications News Feed</title>
    <link>http://www.signaturecomms.com/news_archive/</link>
    <description>Signature Communications News</description>
    <dc:language>en</dc:language>
    <dc:creator>neil@modeten.com</dc:creator>
    <dc:rights>Copyright 2010</dc:rights>
    <dc:date>2010-02-25T14:33:43+00:00</dc:date>
    <admin:generatorAgent rdf:resource="http://expressionengine.com/" />
    

    <item>
      <title>Signature Communications lands brief to handle Botox rival</title>
      <link>http://www.signaturecomms.com/news/signature_communications_lands_brief_to_handle_botox_rival/</link>
      <guid>http://www.signaturecomms.com/news/signature_communications_lands_brief_to_handle_botox_rival/#When:14:33:43Z</guid>
      <description>Dermatology firm Galderma has turned to Signature Communications to promote a new cosmetic product to take on market leader Botox.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2010-02-25T14:33:43+00:00</dc:date>
    </item>

    <item>
      <title>Basilea Brings in Signature Communications</title>
      <link>http://www.signaturecomms.com/news/basilea_brings_in_signature_communications/</link>
      <guid>http://www.signaturecomms.com/news/basilea_brings_in_signature_communications/#When:14:53:25Z</guid>
      <description>Signature Communications has been brought in to support a medical education campaign for Toctino® (alitretinoin) following its approval for Repeat&#45;use Procedure in 13 additional European Union (EU) Member States. Toctino® is a new once&#45;daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2010-02-08T14:53:25+00:00</dc:date>
    </item>

    <item>
      <title>Sun Smart, Skin Aware &#45; Communiqué</title>
      <link>http://www.signaturecomms.com/news/sun_smart_skin_aware_communique/</link>
      <guid>http://www.signaturecomms.com/news/sun_smart_skin_aware_communique/#When:15:23:32Z</guid>
      <description>Thirty to forty years ago, sun awareness campaigns to convey skin damage did not exist. As a result, a large percentage of the UK population aged 50+ now have signs of sun damage and are widely susceptible to non&#45;melanoma skin cancers such as actinic keratosis, basal cell carcinoma and squamous cell carcinoma.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-11-27T15:23:32+00:00</dc:date>
    </item>

    <item>
      <title>Signature Secures Scar Prevention Brief</title>
      <link>http://www.signaturecomms.com/news/signature_secures_scar_prevention_brief/</link>
      <guid>http://www.signaturecomms.com/news/signature_secures_scar_prevention_brief/#When:15:16:18Z</guid>
      <description>Signature Healthcare Communications has been bought onboard by Cranage Healthcare to undertake the UK launch and ongoing promotion of its clinically proven scar prevention treatment, Kelo&#45;cote®.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-06-03T15:16:18+00:00</dc:date>
    </item>

    <item>
      <title>Signature Healthcare Communications Handed Solaraze Brief</title>
      <link>http://www.signaturecomms.com/news/signature_healthcare_communications_handed_solaraze_brief/</link>
      <guid>http://www.signaturecomms.com/news/signature_healthcare_communications_handed_solaraze_brief/#When:12:04:19Z</guid>
      <description>Almirall UK has appointed Signature Healthcare Communications as its UK medical education and PR agency.  The agency has been appointed following a competitive pitch and will work initially on the Solaraze brand, as well as the wider dermatology portfolio later this year.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-04-08T12:04:19+00:00</dc:date>
    </item>

    <item>
      <title>Signature Healthcare Communications Secures Galderma Brief</title>
      <link>http://www.signaturecomms.com/news/signature_healthcare_communications_secures_galderma_brief_/</link>
      <guid>http://www.signaturecomms.com/news/signature_healthcare_communications_secures_galderma_brief_/#When:17:36:37Z</guid>
      <description>Dermatology experts Galderma have appointed Signature Communications to spearhead its national PR and medical education account.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-03-19T17:36:37+00:00</dc:date>
    </item>

    <item>
      <title>A New Face at Signature&#8230;</title>
      <link>http://www.signaturecomms.com/news/a_new_face_at_signature/</link>
      <guid>http://www.signaturecomms.com/news/a_new_face_at_signature/#When:21:38:26Z</guid>
      <description>Following a number of new client wins, we are thrilled to announce that from Monday 6th April we will be welcoming Carol Singleton to the team.  With over six years experience working in pharmaceutical PR and events, Carol brings a wealth of experience and exceptional organisational talents to the team.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-03-18T21:38:26+00:00</dc:date>
    </item>

    <item>
      <title>Conferences Are Us!</title>
      <link>http://www.signaturecomms.com/news/conferences_are_us/</link>
      <guid>http://www.signaturecomms.com/news/conferences_are_us/#When:21:29:21Z</guid>
      <description>After three months of planning, we are now just a week away from SKCIN’s launch at the inaugural “Skin Cancer UK, A United National Strategy” conference.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-03-18T21:29:21+00:00</dc:date>
    </item>

    <item>
      <title>Computertan Hoax Fools Millions&#8230;</title>
      <link>http://www.signaturecomms.com/news/computertan_hoax_fools_millions/</link>
      <guid>http://www.signaturecomms.com/news/computertan_hoax_fools_millions/#When:21:28:18Z</guid>
      <description>...into Seeing Dangers of Skin Cancer.  This month we worked alongside leading advertising agency, McCann Ericksson to launch a skin cancer awareness campaign on behalf our client, SKCIN.</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-03-18T21:28:18+00:00</dc:date>
    </item>

    <item>
      <title>Always one for a challenge!</title>
      <link>http://www.signaturecomms.com/news/always_one_for_a_challenge/</link>
      <guid>http://www.signaturecomms.com/news/always_one_for_a_challenge/#When:21:22:40Z</guid>
      <description>How else can you respond when a new client presents you with the challenge &#39;you have six weeks to plan the tactics and implement a national healthcare professional launch meeting for a new first in class drug&#39;; than to pick up the reins and race off?</description>
      <dc:subject>Signature Communications Healthcare News</dc:subject>
      <dc:date>2009-03-18T21:22:40+00:00</dc:date>
    </item>

    
    </channel>
</rss>